No Detail Found!

Impact of Rituximab and IPI on survival in diffuse large B cell Lymphoma patients treated at a tertiary level cancer centre in Pakistan: a single-centre experience.

Author(s)
Sohail Athar Departmentof Medical Oncology, Shaukat Khanum MemorialCancer Hospital and Research Centre(SKMCH), Lahore, Pakistan
Neelam Siddiqui Departmentof Medical Oncology, Shaukat Khanum MemorialCancer Hospital and Research Centre(SKMCH), Lahore, Pakistan
Sulaman Raza Rai Departmentof Medical Oncology, Shaukat Khanum MemorialCancer Hospital and Research Centre(SKMCH), Lahore, Pakistan
Narjis Muzaffar Departmentof Medical Oncology, Shaukat Khanum MemorialCancer Hospital and Research Centre(SKMCH), Lahore, Pakistan
Abdul-Hameed Departmentof Medical Oncology, Shaukat Khanum MemorialCancer Hospital and Research Centre(SKMCH), Lahore, Pakistan
Abstract
Objective: To determine the impact of Rituximab and international prognostic index score on survival in diffuse large B-cell lymphoma patients. Method: The retrospective study was conducted at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, fromJanuary to May 2013 and comprised record of patients with diffuse large B-cell lymphoma who were treated from2007 to 2010. Baseline international prognostic index score, stage at presentation were noted and the records were divided into two groups A and B on the basis of the type of chemotherapy. SPSS 19 was used for statistical analysis. Results: Of the 93 patients in the study whose records were reviewed, 54(58%) were men. Overall median age was 43 years (range: 18-76). Stages at presentation were stage-I 14 (15.1%), stage-II 41 (44.1%), stage-III 20 (21.5%) and stage-IV 18 (19.4%). International prognostic index risk categorisation was low risk 59(63.4%), low intermediate risk 23(24.7%), high intermediate risk 10(10.8%) and high risk 1(1.1%). There were 31(33%) patients in Group A and 62(67%) in Group B. Median follow-up was 3.9 years (range: 1.2-6.1). Overall survival at 4 years was 66.4%; for Group A 65.3% and for Group B 66.7% (p
Publication Details
Page(s) 170-174
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 65, Issue: 2, Year: 2015

Request the full text from PASTIC

0

Citations

0

Downloads

61

Views